Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind ...
British medical devices maker Smith+Nephew topped expectations for first-quarter sales on Thursday, buoyed by a rebound in elective surgeries and robust demand for its products.
LONDON, April 24, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced its new CORI™ Digital Tensioner - a purpose built device that lets ...
TipRanks on MSN
Smith & Nephew Announces Key ADS Purchase by Executive
Smith & Nephew Snats ( ($SNN) ) has issued an announcement. On November 6, 2025, Smith & Nephew plc announced a significant transaction involving ...
LONDON, March 7, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced the UltraTRAC™ QUAD ACL Reconstruction Technique which consists of the ...
Smith+Nephew (NYSE: SNN) shares dipped before hours today on third-quarter results that failed to reach the consensus sales ...
Business: Smith & Nephew is a British portfolio medical technology company that operates worldwide. The company develops, manufactures, markets and sells medical devices and services. Its segments ...
Smith & Nephew Snats (($SNN)) announced an update on their ongoing clinical study. Smith & Nephew is conducting a multi-centre study titled ‘A ...
Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.
(Alliance News) - Smith & Nephew PLC on Thursday raised its annual free cash flow outlook, but shares slumped as third quarter revenue fell short of consensus.
Shares of Smith & Nephew fell nearly 9% on Thursday after the British medical products maker missed analyst estimates for quarterly revenue due to weakness in its U.S. knee implants business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback